Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Small Cap Biotech Stocks Are Trending Well

Article By:
Rod Raynovich
Monday, July 18, 2022 4:14 AM EST
Despite a little weakness last week, small cap biotechs are trending well for traders. For investors entering the trade on July 5 all of our. focus stocks are up except ChemoCentryx.
Exact Sciences Is Going Higher

Article By:
Quad 7 Capital
Tuesday, July 30, 2019 12:23 PM EST
With the merger of Exact Sciences and Genomic Health, investors should be looking for EXAS earnings positive results by the end of 2020. In the meantime, revenue growth continues to be astounding.
Triple Play Acquiring Triple Play

Article By:
Bespoke Investment Group
Monday, July 29, 2019 1:14 PM EST
Exact Sciences announced plans today to acquire another health care company, Genomic Health. The two announced that the agreement would combine Exact Sciences with Genomic Health for $72 per share in cash and stock.
Exact Sciences: Poised For Further Growth
Great article! Analyst consensus = strong buy with $90 price target. $PFE $EXAS
Exact Sciences: Poised For Further Growth
Article is a good summary and is likely representative of the future for $EXAS.